Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Development of a Caregiver-Reported Experience Measure for Pediatric Hospital-to-Home Transitions.

Desai AD, Jacob-Files EA, Lowry SJ, Opel DJ, Mangione-Smith R, Britto MT, Howard WJ.

Health Serv Res. 2018 Aug;53 Suppl 1:3084-3106. doi: 10.1111/1475-6773.12864. Epub 2018 May 8.

PMID:
29740810
2.

Longitudinal change in parent and child functioning after internet-delivered cognitive-behavioral therapy for chronic pain.

Law EF, Fisher E, Howard WJ, Levy R, Ritterband L, Palermo TM.

Pain. 2017 Oct;158(10):1992-2000. doi: 10.1097/j.pain.0000000000000999.

3.

Embedding clinical interventions into observational studies.

Newman AB, Avilés-Santa ML, Anderson G, Heiss G, Howard WJ, Krucoff M, Kuller LH, Lewis CE, Robinson JG, Taylor H, Treviño RP, Weintraub W.

Contemp Clin Trials. 2016 Jan;46:100-105. doi: 10.1016/j.cct.2015.11.017. Epub 2015 Dec 2.

4.

Using Principal Components as Auxiliary Variables in Missing Data Estimation.

Howard WJ, Rhemtulla M, Little TD.

Multivariate Behav Res. 2015;50(3):285-99. doi: 10.1080/00273171.2014.999267. Epub 2015 May 26.

PMID:
26610030
5.

All-cause, cardiovascular, and cancer mortality in western Alaska Native people: western Alaska Tribal Collaborative for Health (WATCH).

Howard BV, Metzger JS, Koller KR, Jolly SE, Asay ED, Wang H, Wolfe AW, Hopkins SE, Kaufmann C, Raymer TW, Trimble B, Provost EM, Ebbesson SO, Austin MA, Howard WJ, Umans JG, Boyer BB.

Am J Public Health. 2014 Jul;104(7):1334-40. doi: 10.2105/AJPH.2013.301614. Epub 2014 Apr 22.

6.

Pathways of influence in school-based mentoring: the mediating role of parent and teacher relationships.

Chan CS, Rhodes JE, Howard WJ, Lowe SR, Schwartz SE, Herrera C.

J Sch Psychol. 2013 Feb;51(1):129-42. doi: 10.1016/j.jsp.2012.10.001. Epub 2012 Oct 31.

7.

Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States.

Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, Lewis JS 2nd, Howard WJ, Johnson LE, Polsky B, Jorgensen JH, Richter SS, Shutt KA, Paterson DL.

Clin Infect Dis. 2013 Mar;56(5):641-8. doi: 10.1093/cid/cis942. Epub 2012 Nov 13.

8.

Differences in risk factors for coronary heart disease among diabetic and nondiabetic individuals from a population with high rates of diabetes: the Strong Heart Study.

Xu J, Lee ET, Peterson LE, Devereux RB, Rhoades ER, Umans JG, Best LG, Howard WJ, Paranilam J, Howard BV.

J Clin Endocrinol Metab. 2012 Oct;97(10):3766-74. doi: 10.1210/jc.2012-2110. Epub 2012 Jul 16.

9.

Lipid-related markers and cardiovascular disease prediction.

Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, Butterworth AS, Sarwar N, Wormser D, Saleheen D, Ballantyne CM, Psaty BM, Sundström J, Ridker PM, Nagel D, Gillum RF, Ford I, Ducimetiere P, Kiechl S, Koenig W, Dullaart RP, Assmann G, D'Agostino RB Sr, Dagenais GR, Cooper JA, Kromhout D, Onat A, Tipping RW, Gómez-de-la-Cámara A, Rosengren A, Sutherland SE, Gallacher J, Fowkes FG, Casiglia E, Hofman A, Salomaa V, Barrett-Connor E, Clarke R, Brunner E, Jukema JW, Simons LA, Sandhu M, Wareham NJ, Khaw KT, Kauhanen J, Salonen JT, Howard WJ, Nordestgaard BG, Wood AM, Thompson SG, Boekholdt SM, Sattar N, Packard C, Gudnason V, Danesh J.

JAMA. 2012 Jun 20;307(23):2499-506. doi: 10.1001/jama.2012.6571.

10.

Heart rate is associated with markers of fatty acid desaturation: the GOCADAN study.

Ebbesson SO, Lopez-Alvarenga JC, Okin PM, Devereux RB, Tejero ME, Harris WS, Ebbesson LO, MacCluer JW, Wenger C, Laston S, Fabsitz RR, Kennish J, Howard WJ, Howard BV, Umans J, Comuzzie AG.

Int J Circumpolar Health. 2012 Mar 19;71:17343. doi: 10.3402/ijch.v71i0.17343.

11.

Differential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial.

Roman MJ, Howard BV, Howard WJ, Mete M, Fleg JL, Lee ET, Devereux RB.

Hypertension. 2011 Sep;58(3):367-71. doi: 10.1161/HYPERTENSIONAHA.111.172486. Epub 2011 Jul 25.

12.

Relationship of glycemia control to lipid and blood pressure lowering and atherosclerosis: the SANDS experience.

Mete M, Wilson C, Lee ET, Silverman A, Russell M, Stylianou M, Umans JG, Wang W, Howard WJ, Ratner RE, Howard BV, Fleg JL.

J Diabetes Complications. 2011 Nov-Dec;25(6):362-7. doi: 10.1016/j.jdiacomp.2011.04.001. Epub 2011 Jul 19.

13.

Prevalence and genetic relatedness of methicillin-susceptible Staphylococcus aureus isolates detected by the Xpert MRSA nasal assay.

Arbefeville SS, Zhang K, Kroeger JS, Howard WJ, Diekema DJ, Richter SS.

J Clin Microbiol. 2011 Aug;49(8):2996-9. doi: 10.1128/JCM.00046-11. Epub 2011 Jun 15.

14.

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.

Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, Goldberg AC, Howard WJ, Jacobson MS, Kris-Etherton PM, Lennie TA, Levi M, Mazzone T, Pennathur S; American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease.

Circulation. 2011 May 24;123(20):2292-333. doi: 10.1161/CIR.0b013e3182160726. Epub 2011 Apr 18. No abstract available.

PMID:
21502576
15.

Heart rate is associated with red blood cell fatty acid concentration: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.

Ebbesson SO, Devereux RB, Cole S, Ebbesson LO, Fabsitz RR, Haack K, Harris WS, Howard WJ, Laston S, Lopez-Alvarenga JC, MacCluer JW, Okin PM, Tejero ME, Voruganti VS, Wenger CR, Howard BV, Comuzzie AG.

Am Heart J. 2010 Jun;159(6):1020-5. doi: 10.1016/j.ahj.2010.03.001.

16.

Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) .

Wilson C, Huang CC, Shara N, Howard BV, Fleg JL, Henderson JA, Howard WJ, Huentelman H, Lee ET, Mete M, Russell M, Galloway JM, Silverman A, Stylianou M, Umans J, Weir MR, Yeh F, Ratner RE.

J Clin Lipidol. 2010 May-Jun;4(3):165-72. doi: 10.1016/j.jacl.2010.01.008.

17.

The role of ezetimibe in the prevention of cardiovascular disease: where do we stand after ARBITER 6-HALTS.

Howard WJ.

Nutr Metab Cardiovasc Dis. 2010 Jun;20(5):295-300. Erratum in: Nutr Metab Cardiovasc Dis. 2011 May;21(5):390.

PMID:
20556890
18.

All-cause and CVD mortality in Native Hawaiians.

Aluli NE, Reyes PW, Brady SK, Tsark JU, Jones KL, Mau M, Howard WJ, Howard BV.

Diabetes Res Clin Pract. 2010 Jul;89(1):65-71. doi: 10.1016/j.diabres.2010.03.003. Epub 2010 Apr 14.

19.

Comparison of BD Phoenix AP Workflow with Vitek 2.

Junkins AD, Arbefeville SS, Howard WJ, Richter SS.

J Clin Microbiol. 2010 May;48(5):1929-31. doi: 10.1128/JCM.00111-10. Epub 2010 Mar 10.

20.

PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDY.

Howard WJ, Russell M, Fleg JL, Mete M, Ali T, Devereux RB, Galloway JM, Otvos JD, Ratner RE, Roman MJ, Silverman A, Umans JG, Weissman NJ, Wilson C, Howard BV.

J Clin Lipidol. 2009 Oct 1;3(5):322-331.

21.

Relation among lipoprotein subfractions and carotid atherosclerosis in Alaskan Eskimos (from the GOCADAN Study).

Masulli M, Patti L, Riccardi G, Vaccaro O, Annuzzi G, Ebbesson SO, Fabsitz RR, Howard WJ, Otvos JD, Roman MJ, Wang H, Weissman NJ, Howard BV, Rivellese AA.

Am J Cardiol. 2009 Dec 1;104(11):1516-21. doi: 10.1016/j.amjcard.2009.07.021. Epub 2009 Oct 14.

22.

Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial.

Weir MR, Yeh F, Silverman A, Devereux RB, Galloway JM, Henderson JA, Howard WJ, Russell M, Wilson C, Ratner R, Sorkin J, Umans JG, Fleg JL, Stylianou M, Lee E, Howard BV.

J Clin Hypertens (Greenwich). 2009 Oct;11(10):540-8. doi: 10.1111/j.1751-7176.2009.00121.x.

23.

Cardiovascular disease prevalence and its relation to risk factors in Alaska Eskimos.

Howard BV, Comuzzie A, Devereux RB, Ebbesson SO, Fabsitz RR, Howard WJ, Laston S, MacCluer JW, Silverman A, Umans JG, Wang H, Weissman NJ, Wenger CR.

Nutr Metab Cardiovasc Dis. 2010 Jun;20(5):350-8. doi: 10.1016/j.numecd.2009.04.010. Epub 2009 Oct 2.

24.

Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.

Fleg JL, Mete M, Howard BV, Umans JG, Roman MJ, Ratner RE, Silverman A, Galloway JM, Henderson JA, Weir MR, Wilson C, Stylianou M, Howard WJ.

J Am Coll Cardiol. 2008 Dec 16;52(25):2198-205. doi: 10.1016/j.jacc.2008.10.031.

25.

Incidence and risk factors for stroke in American Indians: the Strong Heart Study.

Zhang Y, Galloway JM, Welty TK, Wiebers DO, Whisnant JP, Devereux RB, Kizer JR, Howard BV, Cowan LD, Yeh J, Howard WJ, Wang W, Best L, Lee ET.

Circulation. 2008 Oct 7;118(15):1577-84. doi: 10.1161/CIRCULATIONAHA.108.772285. Epub 2008 Sep 22.

26.

C-Reactive protein, insulin resistance, and metabolic syndrome in a population with a high burden of subclinical infection: insights from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.

Howard BV, Best L, Comuzzie A, Ebbesson SO, Epstein SE, Fabsitz RR, Howard WJ, Silverman A, Wang H, Zhu J, Umans J.

Diabetes Care. 2008 Dec;31(12):2312-4. doi: 10.2337/dc08-0815. Epub 2008 Sep 16.

27.

Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.

Howard BV, Roman MJ, Devereux RB, Fleg JL, Galloway JM, Henderson JA, Howard WJ, Lee ET, Mete M, Poolaw B, Ratner RE, Russell M, Silverman A, Stylianou M, Umans JG, Wang W, Weir MR, Weissman NJ, Wilson C, Yeh F, Zhu J.

JAMA. 2008 Apr 9;299(14):1678-89. doi: 10.1001/jama.299.14.1678.

28.

Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study.

Rivellese AA, Patti L, Kaufman D, Zhu J, Annuzzi G, Vaccaro O, Ebbesson SO, Howard WJ, Riccardi G, Howard BV.

Atherosclerosis. 2008 Oct;200(2):350-8. doi: 10.1016/j.atherosclerosis.2007.12.041. Epub 2008 Apr 18.

29.

Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey.

Hirsch AT, Murphy TP, Lovell MB, Twillman G, Treat-Jacobson D, Harwood EM, Mohler ER 3rd, Creager MA, Hobson RW 2nd, Robertson RM, Howard WJ, Schroeder P, Criqui MH; Peripheral Arterial Disease Coalition.

Circulation. 2007 Oct 30;116(18):2086-94. Epub 2007 Sep 17.

PMID:
17875966
30.

Multicenter evaluation of the BD Phoenix Automated Microbiology System for antimicrobial susceptibility testing of Streptococcus species.

Richter SS, Howard WJ, Weinstein MP, Bruckner DA, Hindler JF, Saubolle M, Doern GV.

J Clin Microbiol. 2007 Sep;45(9):2863-71. Epub 2007 Jul 25.

31.

The process of care of battle casualties: orthopaedics and rehabilitation at the Walter Reed Army Medical Center.

Doukas WC, Javernick MA, Springer BA, Pasquina PF, Gambel J, Foster LS, Kim A, Howard WJ 3rd.

US Army Med Dep J. 2007 Jan-Mar:38-50. No abstract available.

PMID:
20084704
32.
33.

The metabolic syndrome: is a critical appraisal really necessary? The point of view of a practicing physician.

Howard WJ.

Nutr Metab Cardiovasc Dis. 2006 Mar;16(2):85-7. No abstract available.

PMID:
16487907
34.

Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors.

Howard BV, Best LG, Galloway JM, Howard WJ, Jones K, Lee ET, Ratner RE, Resnick HE, Devereux RB.

Diabetes Care. 2006 Feb;29(2):391-7.

PMID:
16443893
35.

Carpal tunnel syndrome and cubital tunnel syndrome: work-related musculoskeletal disorders in four symptomatic radiologists.

Ruess L, O'Connor SC, Cho KH, Hussain FH, Howard WJ 3rd, Slaughter RC, Hedge A.

AJR Am J Roentgenol. 2003 Jul;181(1):37-42.

PMID:
12818826
36.

Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study.

Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ, Robbins DC, Howard BV.

Diabetes Care. 2003 Jan;26(1):16-23.

PMID:
12502653
37.

Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors.

Grundy SM, Garber A, Goldberg R, Havas S, Holman R, Lamendola C, Howard WJ, Savage P, Sowers J, Vega GL.

Circulation. 2002 May 7;105(18):e153-8. No abstract available.

PMID:
11994266
38.

Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia.

Anderson JW, Davidson MH, Blonde L, Brown WV, Howard WJ, Ginsberg H, Allgood LD, Weingand KW.

Am J Clin Nutr. 2000 Jun;71(6):1433-8.

PMID:
10837282
39.

LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study.

Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB, Cowan LD, Gray RS, Welty TK, Go OT, Howard WJ.

Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):830-5.

PMID:
10712410
40.

Rising tide of cardiovascular disease in American Indians. The Strong Heart Study.

Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, Howard WJ, Rhoades ER, Robbins DC, Sievers ML, Welty TK.

Circulation. 1999 May 11;99(18):2389-95.

PMID:
10318659
41.
42.

LDL cholesterol and troglitazone therapy.

Howard BV, Howard WJ.

Diabetes Care. 1998 Dec;21(12):2201-3. No abstract available.

PMID:
9839127
43.

All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study.

Lee ET, Cowan LD, Welty TK, Sievers M, Howard WJ, Oopik A, Wang W, Yeh J, Devereux RB, Rhoades ER, Fabsitz RR, Go O, Howard BV.

Am J Epidemiol. 1998 Jun 1;147(11):995-1008.

PMID:
9620042
44.
45.

Binding affinity and particle size of LDL in subjects with moderate hypercholesterolemia: relationship with in vivo LDL metabolism.

Yamane K, Kataoka S, Le NA, Paidi M, Howard WJ, Hannah JS, Howard BV.

J Lipid Res. 1996 Aug;37(8):1646-54.

46.

Vitek GPS card susceptibility testing accuracy using direct inoculation from BACTEC 9240 blood culture bottles.

Howard WJ, Buschelman BJ, Bale MJ, Pfaller MA, Koontz FP, Jones RN.

Diagn Microbiol Infect Dis. 1996 Feb;24(2):109-12.

PMID:
9147906
47.

Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study.

Howard BV, Lee ET, Cowan LD, Fabsitz RR, Howard WJ, Oopik AJ, Robbins DC, Savage PJ, Yeh JL, Welty TK.

Am J Epidemiol. 1995 Aug 1;142(3):254-68.

PMID:
7631630
48.

Polyunsaturated fatty acids result in greater cholesterol lowering and less triacylglycerol elevation than do monounsaturated fatty acids in a dose-response comparison in a multiracial study group.

Howard BV, Hannah JS, Heiser CC, Jablonski KA, Paidi MC, Alarif L, Robbins DC, Howard WJ.

Am J Clin Nutr. 1995 Aug;62(2):392-402.

PMID:
7625348
49.

Long-term treatment of hypercholesterolemia with dietary fiber.

Hunninghake DB, Miller VT, LaRosa JC, Kinosian B, Jacobson T, Brown V, Howard WJ, Edelman DA, O'Connor RR.

Am J Med. 1994 Dec;97(6):504-8.

PMID:
7985708
50.

Dyslipidemia in non-insulin-dependent diabetes mellitus.

Howard BV, Howard WJ.

Endocr Rev. 1994 Jun;15(3):263-74. Review. No abstract available. Erratum in: Endocr Rev 1994 Aug;15(4):438.

PMID:
8076581

Supplemental Content

Loading ...
Support Center